CRISPR Therapeutics AG — All Filings
828 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-25-090170 | Jun 26, 2025 | — |
| 3/A | 3/A | 0000950170-25-084490 | Jun 10, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0000950170-25-083799 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083269 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083270 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083271 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083272 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083273 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083274 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083289 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083298 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083268 | Jun 6, 2025 | Jun 5, 2025 |
| 3 | 3 | 0000950170-25-083255 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083267 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-081362 | Jun 3, 2025 | May 30, 2025 |
| 4 | 4 | 0000950170-25-081361 | Jun 3, 2025 | May 30, 2025 |
| 4 | 4 | 0000950170-25-079822 | May 30, 2025 | May 28, 2025 |
| 8-K | 8-K | 0000950170-25-074428 | May 19, 2025 | — |
| 424B5 | 424B5 | 0000950170-25-074553 | May 19, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-048312 | May 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001562230-25-000068 | May 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-064468 | May 6, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-064435 | May 6, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-054711 | Apr 16, 2025 | Jun 5, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-054724 | Apr 16, 2025 | — |
| ARS | ARS | 0000950170-25-054744 | Apr 16, 2025 | Dec 31, 2024 |
| PRE 14A | PRE 14A | 0000950170-25-050391 | Apr 3, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0000950170-25-045232 | Mar 26, 2025 | Mar 24, 2025 |
| 4 | 4 | 0000950170-25-043975 | Mar 24, 2025 | Mar 20, 2025 |
| 4 | 4 | 0000950170-25-043974 | Mar 24, 2025 | Mar 20, 2025 |
| 4 | 4 | 0000950170-25-043972 | Mar 24, 2025 | Mar 20, 2025 |
| 4 | 4 | 0000950170-25-043973 | Mar 24, 2025 | Mar 20, 2025 |
| 4 | 4 | 0000950170-25-041467 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | 4 | 0000950170-25-041470 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | 4 | 0000950170-25-041468 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | 4 | 0000950170-25-041469 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | 4 | 0000950170-25-041471 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | 4 | 0000950170-25-038216 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-038215 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-038214 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | 4 | 0000950170-25-030181 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | 4 | 0000950170-25-025000 | Feb 21, 2025 | Feb 19, 2025 |
| 4 | 4 | 0000950170-25-023386 | Feb 19, 2025 | Feb 16, 2025 |
| 4 | 4 | 0000950170-25-023385 | Feb 19, 2025 | Feb 18, 2025 |
| 4 | 4 | 0000950170-25-023387 | Feb 19, 2025 | Feb 18, 2025 |
| 144 | — | 0001958244-25-001197 | Feb 18, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-013688 | Feb 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-017879 | Feb 11, 2025 | — |
| 10-K | 10-K | 0000950170-25-017899 | Feb 11, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001104659-25-002717 | Jan 10, 2025 | — |